Table Of ContentCopyright © National Academy of Sciences. All rights reserved.
Antibiotic Resistance: Implications for Global Health and Novel Intervention Strategies: Workshop Summary
Eileen R. Choffnes, David A. Relman, and Alison Mack, Rapporteurs
Forum on Microbial Threats
Board on Global Health
INSTITUTE OF MEDICINE
OF THE NATIONAL ACADEMIES
THE NATIONAL ACADEMIES PRESS
Washington, D.C.
www.nap.edu
Copyright © National Academy of Sciences. All rights reserved.
Antibiotic Resistance: Implications for Global Health and Novel Intervention Strategies: Workshop Summary
THE NATIONAL ACADEMIES PRESS 500 Fifth Street, N.W. Washington, DC 20001
NOTICE: The project that is the subject of this report was approved by the Governing
Board of the National Research Council, whose members are drawn from the councils of
the National Academy of Sciences, the National Academy of Engineering, and the Institute
of Medicine.
This project was supported by contracts between the National Academy of Sciences and
the U.S. Department of Health and Human Services: National Institutes of Health, National
Institute of Allergy and Infectious Diseases, Centers for Disease Control and Prevention,
and Food and Drug Administration; U.S. Department of Defense, Department of the
Army: Global Emerging Infections Surveillance and Response System, Medical Research
and Materiel Command, and Defense Threat Reduction Agency; U.S. Department of
Veterans Affairs; U.S. Department of Homeland Security; U.S. Agency for International
Development; American Society for Microbiology; Sanofi Pasteur; Burroughs Wellcome
Fund; Pfizer; GlaxoSmithKline; Infectious Diseases Society of America; and the Merck
Company Foundation. Any opinions, findings, conclusions, or recommendations expressed
in this publication are those of the author(s) and do not necessarily reflect the view of the
organizations or agencies that provided support for this project.
International Standard Book Number-13: 978-0-309-15611-0
International Standard Book Number-10: 0-309-15611-4
Additional copies of this report are available from the National Academies Press, 500 Fifth
Street, N.W., Lockbox 285, Washington, DC 20055; (800) 624-6242 or (202) 334-3313
(in the Washington metropolitan area); Internet, http://www.nap.edu.
For more information about the Institute of Medicine, visit the IOM home page at: www.
iom.edu.
Copyright 2010 by the National Academy of Sciences. All rights reserved.
Printed in the United States of America
The serpent has been a symbol of long life, healing, and knowledge among almost all
cultures and religions since the beginning of recorded history. The serpent adopted as a
logotype by the Institute of Medicine is a relief carving from ancient Greece, now held by
the Staatliche Museen in Berlin.
Cover image: This 2005 colorized scanning electron micrograph depicts numerous clumps
of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. MRSA infections, e.g.,
bloodstream, pneumonia, bone infections, occur most frequently among persons in hos-
pitals and healthcare facilities, including nursing homes and dialysis centers. SOURCE:
CDC, Public Health Image Library (PHIL 10046).
Suggested citation: IOM (Institute of Medicine). 2010. Antibiotic resistance: Implica-
tions for global health and novel intervention strategies. Washington, DC: The National
Academies Press.
Copyright © National Academy of Sciences. All rights reserved.
Antibiotic Resistance: Implications for Global Health and Novel Intervention Strategies: Workshop Summary
“Knowing is not enough; we must apply.
Willing is not enough; we must do.”
—Goethe
Advising the Nation. Improving Health.
Copyright © National Academy of Sciences. All rights reserved.
Antibiotic Resistance: Implications for Global Health and Novel Intervention Strategies: Workshop Summary
The National Academy of Sciences is a private, nonprofit, self-perpetuating society of
distinguished scholars engaged in scientific and engineering research, dedicated to the
furtherance of science and technology and to their use for the general welfare. Upon the
authority of the charter granted to it by the Congress in 1863, the Academy has a mandate
that requires it to advise the federal government on scientific and technical matters. Dr.
Ralph J. Cicerone is president of the National Academy of Sciences.
The National Academy of Engineering was established in 1964, under the charter of
the National Academy of Sciences, as a parallel organization of outstanding engineers.
It is autonomous in its administration and in the selection of its members, sharing with
the National Academy of Sciences the responsibility for advising the federal government.
The National Academy of Engineering also sponsors engineering programs aimed at
meeting national needs, encourages education and research, and recognizes the superior
achievements of engineers. Dr. Charles M. Vest is president of the National Academy of
Engineering.
The Institute of Medicine was established in 1970 by the National Academy of Sciences
to secure the services of eminent members of appropriate professions in the examina-
tion of policy matters pertaining to the health of the public. The Institute acts under the
responsibility given to the National Academy of Sciences by its congressional charter to
be an adviser to the federal government and, upon its own initiative, to identify issues of
medical care, research, and education. Dr. Harvey V. Fineberg is president of the Institute
of Medicine.
The National Research Council was organized by the National Academy of Sciences in
1916 to associate the broad community of science and technology with the Academy’s
purposes of furthering knowledge and advising the federal government. Functioning in
accordance with general policies determined by the Academy, the Council has become the
principal operating agency of both the National Academy of Sciences and the National
Academy of Engineering in providing services to the government, the public, and the
scientific and engineering communities. The Council is administered jointly by both
Academies and the Institute of Medicine. Dr. Ralph J. Cicerone and Dr. Charles M. Vest
are chair and vice chair, respectively, of the National Research Council.
www.national-academies.org
Copyright © National Academy of Sciences. All rights reserved.
Antibiotic Resistance: Implications for Global Health and Novel Intervention Strategies: Workshop Summary
FORUM ON MICROBIAL THREATS1
DAVID A. RELMAN (Chair), Stanford University and Veterans Affairs Palo
Alto Health Care System, Palo Alto, California
JAMES M. HUGHES (Vice Chair), Global Infectious Diseases Program,
Emory University, Atlanta, Georgia
RUTH L. BERKELMAN, Emory University, Center for Public Health
Preparedness and Research, Rollins School of Public Health, Atlanta,
Georgia
ENRIQUETA C. BOND, Consultant, Marshall, Virginia
ROGER G. BREEZE, Centaur Science Group, Washington, DC
STEVEN J. BRICKNER, SJ Brickner Consulting, LLC, Ledyard, Connecticut
PAULA R. BRyANT, Medical S&T Division, Defense Threat Reduction
Agency, Fort Belvoir, VA
JOHN E. BURRIS, Burroughs Wellcome Fund, Research Triangle Park, North
Carolina
GAIL H. CASSELL,2 Eli Lilly & Company, Indianapolis, Indiana
PETER DASZAK,3 EcoHealth Alliance, New York, New York
JEFFERy DUCHIN,3 Public Health–Seattle and King County, Seattle,
Washington
JONATHAN EISEN,3 Genome Center, University of California, Davis
MARK B. FEINBERG, Merck Vaccine Division, Merck & Co., West Point,
Pennsylvania
JACQUELINE FLETCHER,3 Oklahoma State University, Stillwater
S. ELIZABETH GEORGE, Biological and Chemical Countermeasures
Program, Department of Homeland Security, Washington, DC
JESSE L. GOODMAN, Center for Biologics Evaluation and Research, Food
and Drug Administration, Rockville, Maryland
EDUARDO GOTUZZO, Instituto de Medicina Tropical–Alexander von
Humbolt, Universidad Peruana Cayetano Heredia, Lima, Peru
JO HANDELSMAN, Yale University, New Haven, Connecticut
CAROLE A. HEILMAN, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Bethesda, Maryland
DAVID L. HEyMANN, Health Protection Agency, London, United Kingdom
PHILIP HOSBACH, Sanofi Pasteur, Swiftwater, Pennsylvania
STEPHEN ALBERT JOHNSTON, Arizona BioDesign Institute, Arizona State
University, Tempe
1 IOM forums and roundtables do not issue, review, or approve individual documents. The responsi-
bility for the published workshop summary rests with the workshop rapporteurs and the institution.
2 Forum member until October 31, 2010.
3 Forum member since October 15, 2010.
v
Copyright © National Academy of Sciences. All rights reserved.
Antibiotic Resistance: Implications for Global Health and Novel Intervention Strategies: Workshop Summary
KENT KESTER, Walter Reed Army Institute of Research, Silver Spring,
Maryland
GERALD T. KEUSCH, Boston University School of Medicine and Boston
University School of Public Health, Massachusetts
RIMA F. KHABBAZ, Centers for Disease Control and Prevention, Atlanta,
Georgia
LONNIE J. KING, Ohio State University, Columbus
STANLEy M. LEMON, School of Medicine, University of North Carolina,
Chapel Hill
EDWARD McSWEEGAN, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, Bethesda, Maryland
MARK MILLER,3 Fogarty International Center, Bethesda, Maryland
PAUL F. MILLER, Pfizer, Groton, Connecticut
STEPHEN S. MORSE, Center for Public Health Preparedness, Columbia
University, New York
MICHAEL T. OSTERHOLM,2 Center for Infectious Disease Research and
Policy, School of Public Health, University of Minnesota, Minneapolis
GEORGE POSTE, Complex Adaptive Systems Initiative, Arizona State
University, Tempe
JOHN C. POTTAGE, JR., GlaxoSmithKline, Collegeville, Pennsylvania
GARy A. ROSELLE, Veterans Health Administration, Department of
Veterans Affairs, Washington, DC
ALAN RUDOLPH,3 Defense Threat Reduction Agency, Fort Belvoir, Virginia
KEVIN RUSSELL, Global Emerging Infections Surveillance and Response
System, Department of Defense, Silver Spring, Maryland
JANET SHOEMAKER, American Society for Microbiology, Washington, DC
P. FREDERICK SPARLING, University of North Carolina, Chapel Hill
TERENCE TAyLOR, International Council for the Life Sciences,
Washington, DC
MURRAy TROSTLE, U.S. Agency for International Development,
Washington, DC
MARy WILSON,3 Harvard School of Public Health, Harvard University,
Boston, Massachusetts
Staff
EILEEN CHOFFNES, Director
KATE SKOCZDOPOLE, Senior Program Associate (until July 2010)
KATHERINE McCLURE, Senior Program Associate (from May 2010)
LEIGHANNE OLSEN, Program Officer (from June 2010)
COLLIN WEINBERGER, Research Associate (from April 2010)
ROBERT GASIOR, Senior Program Assistant
ALISON MACK, Science Writer
vi
Copyright © National Academy of Sciences. All rights reserved.
Antibiotic Resistance: Implications for Global Health and Novel Intervention Strategies: Workshop Summary
BOARD ON GLOBAL HEALTH1
Richard Guerrant (Chair), Thomas H. Hunter Professor of International
Medicine and Director, Center for Global Health, University of Virginia
School of Medicine, Charlottesville
Jo Ivey Boufford (IOM Foreign Secretary), President, New York Academy of
Medicine, New York
Claire V. Broome, Adjunct Professor, Division of Global Health, Rollins
School of Public Health, Emory University
Jacquelyn C. Campbell, Anna D. Wolf Chair, and Professor, Johns Hopkins
University School of Nursing, Baltimore, Maryland
Thomas J. Coates, Professor, David Geffen School of Medicine, University of
California, Los Angeles, Los Angeles
Valentin Fuster, Director, Wiener Cardiovascular Institute Kravis
Cardiovascular Health Center, and Professor, Cardiology, Mount Sinai
School of Medicine, Mount Sinai Medical Center, New York
Peter J. Hotez, Professor and Chair, Department of Microbiology,
Immunology, and Tropical Medicine, George Washington University,
Washington, DC
Fitzhugh Mullan, Professor, Department of Health Policy, George Washington
University, Washington, DC
Staff
Patrick Kelley, Director
Angela Mensah, Program Associate
1 IOM boards do not review or approve individual workshop summaries and are not asked to en-
dorse conclusions and recommendations. The responsibility for the content of the workshop summary
rests with the authors and the institution.
vii
Copyright © National Academy of Sciences. All rights reserved.
Antibiotic Resistance: Implications for Global Health and Novel Intervention Strategies: Workshop Summary
Copyright © National Academy of Sciences. All rights reserved.
Antibiotic Resistance: Implications for Global Health and Novel Intervention Strategies: Workshop Summary
This report has been reviewed in draft form by individuals chosen for their
diverse perspectives and technical expertise, in accordance with procedures
approved by the National Research Council’s Report Review Committee. The
purpose of this independent review is to provide candid and critical comments
that will assist the institution in making its published report as sound as possible
and to ensure that the report meets institutional standards for objectivity, evi-
dence, and responsiveness to the study charge. The review comments and draft
manuscript remain confidential to protect the integrity of the process. We wish to
thank the following individuals for their review of this report:
Martin Blaser, New York University School of Medicine
Roger G. Breeze, Centaur Science Group
David Heymann, Health Protection Agency, United Kingdom
, United Kingdom
Mary E. Wilson, Harvard School of Public Health
Although the reviewers listed above have provided many constructive com-
ments and suggestions, they were not asked to endorse the final draft of the report
before its release. The review of this report was overseen by Dr. Melvin Worth.
Appointed by the Institute of Medicine, he was responsible for making certain
that an independent examination of this report was carried out in accordance with
institutional procedures and that all review comments were carefully considered.
Responsibility for the final content of this report rests entirely with the authoring
committee and the institution.
ix
Reviewers
